• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sjögren's disease: a new era for clinical trials?

作者信息

Colafrancesco Serena, Priori Roberta

机构信息

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele 20072, Milan, Italy; Rheumatology and Clinical Immunology, Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

UOC di Reumatologia, Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome, Italy; Saint Camillus International University of Health Science, Rome, Italy.

出版信息

Lancet. 2024 Aug 10;404(10452):498-499. doi: 10.1016/S0140-6736(24)01433-8. Epub 2024 Jul 31.

DOI:10.1016/S0140-6736(24)01433-8
PMID:39096923
Abstract
摘要

相似文献

1
Sjögren's disease: a new era for clinical trials?干燥综合征：临床试验的新时代？
Lancet. 2024 Aug 10;404(10452):498-499. doi: 10.1016/S0140-6736(24)01433-8. Epub 2024 Jul 31.
2
Development and Application of the Placebo Response Model in Clinical Trials for Primary Sjögren's Syndrome.原发性干燥综合征临床试验中安慰剂反应模型的建立与应用。
Front Immunol. 2021 Nov 16;12:783246. doi: 10.3389/fimmu.2021.783246. eCollection 2021.
3
The Effect of Polyunsaturated Fatty Acid (PUFA) Supplementation on Clinical Manifestations and Inflammatory Parameters in Individuals with Sjögren's Syndrome: A Literature Review of Randomized Controlled Clinical Trials.多不饱和脂肪酸（PUFA）补充对干燥综合征患者临床表现和炎症参数的影响：随机对照临床试验的文献综述。
Nutrients. 2024 Nov 4;16(21):3786. doi: 10.3390/nu16213786.
4
The Development and Content Validation of the Sjögren's Related Quality of Life Instrument (SRQoL).干燥综合征相关生活质量量表（SRQoL）的开发与内容效度验证
Rheumatol Ther. 2024 Dec;11(6):1591-1609. doi: 10.1007/s40744-024-00718-6. Epub 2024 Oct 10.
5
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.原发性干燥综合征临床试验的入选标准：来自英国原发性干燥综合征注册库的经验教训。
Rheumatology (Oxford). 2016 Mar;55(3):544-52. doi: 10.1093/rheumatology/kev373. Epub 2015 Oct 27.
6
Recent advances in the search for a targeted immunomodulatory therapy for primary Sjögren's syndrome.原发性干燥综合征靶向免疫调节治疗的最新进展。
F1000Res. 2019 Aug 29;8. doi: 10.12688/f1000research.19842.1. eCollection 2019.
7
A first-in-human, prospective pilot trial of umbilical cord-derived mesenchymal stem cell eye drops therapy for patients with refractory non-Sjögren's and Sjögren's syndrome dry eye disease.一项针对难治性非干燥综合征和干燥综合征干眼症患者的脐带间充质干细胞滴眼液疗法的首次人体前瞻性试验。
Stem Cell Res Ther. 2025 Apr 23;16(1):202. doi: 10.1186/s13287-025-04292-8.
8
How to assess treatment efficacy in Sjögren's syndrome?如何评估干燥综合征的治疗效果？
Curr Opin Rheumatol. 2012 May;24(3):281-9. doi: 10.1097/BOR.0b013e3283524c37.
9
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts.基于临床和生物学表现的聚类分析识别干燥综合征的不同亚群：来自横断面巴黎-萨克雷和前瞻性 ASSESS 队列的数据。
Lancet Rheumatol. 2024 Apr;6(4):e216-e225. doi: 10.1016/S2665-9913(23)00340-5. Epub 2024 Mar 1.
10
[Indications and options of new immune modulatory therapies for Sjögren's syndrome].[干燥综合征新免疫调节疗法的适应证及选择]
Z Rheumatol. 2007 Dec;66(8):679-85. doi: 10.1007/s00393-007-0231-z.

引用本文的文献

1
Stability of symptom-based subtypes in Sjogren's disease.基于症状的干燥综合征亚型的稳定性。
RMD Open. 2024 Nov 24;10(4):e004914. doi: 10.1136/rmdopen-2024-004914.